An Application for the Trademark "ACCELERATTR" Has Been Filed by Pfizer Inc.
Saved in:
| Title: | An Application for the Trademark "ACCELERATTR" Has Been Filed by Pfizer Inc. |
|---|---|
| Source: | Cardiovascular Week; 10/6/2025, p3236-3236, 1p |
| Subject Terms: | COMPUTER software, APPLICATION program interfaces, TRADEMARKS, CARDIAC amyloidosis, HEART failure, PHARMACEUTICAL industry |
| Company/Entity: | PFIZER Inc. |
| Abstract: | The article focuses on a trademark application for "ACCELERATTR" submitted by Pfizer Inc., which was made public on September 18, 2025. The application, filed by Janina Gorbach, pertains to downloadable computer software and application programming interface (API) software designed for identifying, viewing, analyzing, and monitoring data related to heart failure and transthyretin amyloid cardiomyopathy. The trademark application falls under international class codes 009 and 042, indicating its relevance to software and technology services. The registrar information for the application is provided, detailing Pfizer Inc.'s legal department location in New York. [Extracted from the article] |
| Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Biomedical Index |
Full Text Finder 
Nájsť tento článok vo Web of Science Be the first to leave a comment!